Auteurs
Analysis
France
Racine
Analysis
France
Exploration
Accueil
Racine
Racine

Movement Disorders (revue) - Analysis (France)

Index « Auteurs » - entrée « Paolo Barone »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Paola S. Denora < Paolo Barone < Paolo Bovi  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 6.
Ident.Authors (with country if any)Title
000198 (2010) Karla Eggert [Allemagne] ; David Squillacote [États-Unis] ; Paolo Barone [Italie] ; Richard Dodel [Allemagne] ; Regina Katzenschlager [Autriche] ; Murat Emre [Turquie] ; Andrew Lees (neurologue) [Royaume-Uni] ; Olivier Rascol [France] ; Werner Poewe [Autriche] ; Eduardo Tolosa [Espagne] ; Claudia Trenkwalder [Allemagne] ; Marco Onofrj [Italie] ; Fabrizio Stocchi [Italie] ; Giuseppe Nappi [Italie] ; Vladimir Kostic [Serbie] ; Jagoda Potic [Serbie] ; Evzen Ruzicka [République tchèque] ; Wolfgang Oertel [Allemagne]Safety and efficacy of perampanel in advanced Parkinson's disease: A randomized, placebo‐controlled study
000199 (2010) Anthony H. V. Schapira [Royaume-Uni] ; Stefan Albrecht [Allemagne] ; Paolo Barone [Italie] ; Cynthia L. Comella [États-Unis] ; Michael P. Mcdermott [États-Unis] ; Yoshikuni Mizuno [Japon] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Kenneth Marek [États-Unis]Rationale for delayed‐start study of pramipexole in Parkinson's disease: The PROUD study
000200 (2010) Robert A. Hauser [États-Unis] ; Anthony H. V. Schapira [Royaume-Uni] ; Olivier Rascol [France] ; Paolo Barone [Italie] ; Yoshikuni Mizuno [Japon] ; Laurence Salin [France] ; Monika Haaksma [Autriche] ; Nolwenn Juhel [France] ; Werner Poewe [Autriche]Randomized, double‐blind, multicenter evaluation of pramipexole extended release once daily in early Parkinson's disease
000202 (2010) Martin Köllensperger [Autriche] ; Felix Geser [Autriche] ; Jean-Pierre Ndayisaba [Autriche] ; Sylvia Boesch [Autriche] ; Klaus Seppi [Autriche] ; Karen Ostergaard [Danemark] ; Erik Dupont [Danemark] ; A. Cardozo [Espagne] ; Eduardo Tolosa [Espagne] ; Michael Abele [Allemagne] ; Thomas Klockgether [Allemagne] ; Farid Yekhlef [France] ; Francois Tison [France] ; Christine Daniels [Allemagne] ; Günther Deuschl [Allemagne] ; Miguel Coelho [Portugal] ; Cristina Sampaio [Portugal] ; Maria Bozi [Royaume-Uni] ; Niall Quinn [Royaume-Uni] ; Anette Schrag [Royaume-Uni] ; Chris J. Mathias [Royaume-Uni] ; Clare Fowler [Royaume-Uni] ; Christer F. Nilsson [Suède] ; H Kan Widner [Suède] ; Nicole Schimke [Allemagne] ; Wolfgang Oertel [Allemagne] ; Francesca Del Sorbo [Italie] ; Alberto Albanese [Italie] ; Maria Teresa Pellecchia [Italie] ; Paolo Barone [Italie] ; Ruth Djaldetti [Israël] ; Carlo Colosimo [Italie] ; Giuseppe Meco [Italie] ; Antonio Gonzalez-Mandly [Espagne] ; Jose Berciano [Espagne] ; Tanya Gurevich [Israël] ; Nir Giladi [Israël] ; Monique Galitzky [France] ; Olivier Rascol [France] ; Christoph Kamm [Allemagne] ; Thomas Gasser [Allemagne] ; Uwe Siebert [Autriche, États-Unis] ; Werner Poewe [Autriche] ; Gregor K. Wenning [Autriche]Presentation, diagnosis, and management of multiple system atrophy in Europe: Final analysis of the European multiple system atrophy registry
000217 (2010) Olivier Rascol [France] ; Paolo Barone [Italie] ; Robert A. Hauser [États-Unis] ; Yoshikuni Mizuno [Japon] ; Werner Poewe [Autriche] ; Anthony H. V. Schapira [Royaume-Uni] ; Laurence Salin [France] ; Mandy Sohr [Allemagne] ; Catherine Debieuvre [France]Efficacy, safety, and tolerability of overnight switching from immediate‐ to once daily extended‐release pramipexole in early Parkinson's disease
000342 (2007) Anette Schrag [Royaume-Uni] ; Paolo Barone [Italie] ; Richard G. Brown [Royaume-Uni] ; Albert F. G. Leentjens [Pays-Bas] ; William M. Mcdonald [États-Unis] ; Sergio Starkstein [Australie] ; Daniel Weintraub [États-Unis] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Cristina Sampaio [Portugal] ; Glenn T. Stebbins [États-Unis] ; Christopher G. Goetz [États-Unis]Depression rating scales in Parkinson's disease: Critique and recommendations

List of associated KwdEn.i

Nombre de
documents		Descripteur
6Humans
6Nervous system diseases
5Female
5Male
5Middle Aged
5Parkinson disease
5Parkinson's disease
4Aged
4Double-Blind Method
4Parkinson Disease (drug therapy)
4Severity of Illness Index
3Antiparkinson Agents (administration & dosage)
3Antiparkinson Agents (adverse effects)
3Antiparkinson Agents (therapeutic use)
3Benzothiazoles (administration & dosage)
3Pramipexole
2Adult
2Benzothiazoles (adverse effects)
2Delayed-Action Preparations (therapeutic use)
2Dopamine agonist
2Drug Administration Schedule
2Levodopa (therapeutic use)
2Quality of Life
2Release
2Safety
2Treatment Outcome
2dopamine agonist
1AMPA receptor
1AMPA receptor antagonist
1Advanced stage
1Age of Onset
1Benzothiazoles (therapeutic use)
1Cerebellar Ataxia (diagnosis)
1Cerebellar Ataxia (physiopathology)
1Clinical management
1Cognition Disorders (diagnosis)
1Cognition Disorders (epidemiology)
1Confidence Intervals
1Delayed-Action Preparations (administration & dosage)
1Delayed-Action Preparations (adverse effects)
1Depression
1Depressive Disorder, Major (diagnosis)
1Depressive Disorder, Major (epidemiology)
1Diagnosis
1Diagnosis, Differential
1Diagnostic and Statistical Manual of Mental Disorders
1Dose-Response Relationship, Drug
1Drug Delivery Systems (methods)
1Dyskinesia
1EMSA‐SG
1Europe
1Evaluation
1Fluctuations
1Hypotension, Orthostatic (diagnosis)
1Hypotension, Orthostatic (physiopathology)
1Multiple System Atrophy (diagnosis)
1Multiple System Atrophy (physiopathology)
1Multiple System Atrophy (therapy)
1Multiple system atrophy
1Pain Measurement
1Parkinson Disease (epidemiology)
1Parkinson Disease (physiopathology)
1Parkinsonian Disorders (diagnosis)
1Parkinsonian Disorders (drug therapy)
1Parkinsonian Disorders (physiopathology)
1Patient Satisfaction
1Perampanel
1Placebo
1Prevalence
1Psychometrics
1Psychometrics (statistics & numerical data)
1Pyridones (therapeutic use)
1Questionnaires
1Receptors, AMPA (antagonists & inhibitors)
1Recommendation
1Registries
1Shy-Drager Syndrome (diagnosis)
1Shy-Drager Syndrome (physiopathology)
1Time Factors
1Treatment
1clinical trial
1delayed‐start
1depression
1dyskinesia
1motor fluctuations
1multiple system atrophy
1natural history
1neuroprotection
1perampanel
1pramipexole
1pramipexole extended release
1pramipexole‐extended release
1psychiatric status rating scales
1psychometrics
1switch trial
1treatment

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/France/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i -k "Paolo Barone" 

HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i  \
                -Sk "Paolo Barone" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    France
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Paolo Barone
}}
Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024